Tune in tonight for webinar #KetamineTherapy: Updates from the Field with our very own Abid Nazeer, M.D.,FASAM!
We're very excited to announce this month's members-only webinar: Ketamine Therapy: Updates from the Field! Register: https://buff.ly/3LtQPoF As the date draws nearer for a final decision from the FDA on MDMA-assisted therapy, we thought it was a good time to keep hope alive by revisiting the currently-available psychedelic therapeutic: ketamine. Several new studies have been published since our last webinar on ketamine, and some new formulations have gotten attention as of late, so we wanted to check in with some of those on the front lines of ketamine therapy to find out what practices regarding ketamine therapy are working well and which may not be as effective. This month we are truly fortunate to have panelists working in ketamine clinics from three different areas of the country discussing a number of topics relevant to the therapeutic use of ketamine, including: • Advantages of Ketamine (compared to other psychedelics) • The future landscape of ketamine • What may happen to ketamine clinics as psychedelics get approved …and much more! Panelists joining us for this month's event are: Abid Nazeer, MD, FASAM | Founder & Chief Medical Officer, Hopemark Health David Feifel, MD, PhD | President & Founder, Kadima Neuropsychiatry Institute Greg Jones, CRNA, MS, BSN | Nurse Anesthetist, Co-Founder, & Clinic Director, Radiance Ketamine Clinic As always, there will be ample time for audience Q&A, so you’ll get to interact with the panelists directly! So please join us for this live panel discussion on Thursday, July 25th at 5 pm Pacific, 8 pm Eastern. Register: https://buff.ly/3LtQPoF